
[Federal Register: October 18, 2010 (Volume 75, Number 200)]
[Notices]               
[Page 63845]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18oc10-72]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0389]

 
Medical Device User Fees; Public Meeting; Extension of Comment 
Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is extending to 
November 1, 2010, the comment period for the notice that appeared in 
the Federal Register of August 13, 2010 (75 FR 49502). In the notice, 
FDA requested input and comments from interested stakeholders on the 
Agency's medical user fee program and requested suggestions regarding 
the commitments FDA should propose for the next reauthorized program. 
The Agency is taking this action to allow interested persons additional 
time to submit comments.

DATES: Submit either electronic or written comments and information by 
November 1, 2010.

ADDRESSES: Submit electronic comments to http://www.regulations.gov. 
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852. To ensure consideration, all comments must be 
received by November 1, 2010. Identify comments with the docket number 
found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993-0002, 301-796-6313, 
FAX: 301-847-8121, e-mail: James.Swink@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of August 13, 2010 (75 FR 49502), FDA 
published a notice announcing a public meeting on September 14, 2010, 
and the opening of a public docket to seek input and comments from 
interested stakeholders to discuss the Agency's medical user fee 
program and requested suggestions regarding the commitments FDA should 
propose for the next reauthorized program. Interested persons were 
invited to submit comments to the public docket by October 14, 2010. At 
this time, the Agency is announcing its intention to post the 
transcript of the September 14, 2010, public meeting and is extending 
the comment period until November 1, 2010, to continue to receive 
public comments.

II. Request for Comments

    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) either electronic or written comments regarding this 
document. It is only necessary to send one set of comments. It is no 
longer necessary to send two copies of mailed comments. Identify 
comments with the docket number found in brackets in the heading of 
this document. Received comments may be seen in the Division of Dockets 
Management between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: October 14, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-26253 Filed 10-14-10; 4:15 pm]
BILLING CODE 4160-01-P

